SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-438876
Filing Date
2013-11-13
Accepted
2013-11-12 21:08:50
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d599725d10q.htm 10-Q 285698
2 EX-31.1 d599725dex311.htm EX-31.1 6632
3 EX-31.2 d599725dex312.htm EX-31.2 6632
4 EX-32.1 d599725dex321.htm EX-32.1 5160
  Complete submission text file 0001193125-13-438876.txt   2198688

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT oxgn-20130930.xml EX-101.INS 239712
6 XBRL TAXONOMY EXTENSION SCHEMA oxgn-20130930.xsd EX-101.SCH 22582
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxgn-20130930_cal.xml EX-101.CAL 27874
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oxgn-20130930_def.xml EX-101.DEF 52600
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxgn-20130930_lab.xml EX-101.LAB 208460
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxgn-20130930_pre.xml EX-101.PRE 130885
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 131212203
SIC: 2836 Biological Products, (No Diagnostic Substances)